Free subscription to the Capitol Journal keeps you current on legislative and regulatory news.
Glowing Progress Report on FL Insurance Market from Gallagher Re The insurance industry reforms enacted in Florida in 2022 and 2023 in response to soaring homeowners’ premiums and carrier insolvencies...
CA Enacts AI Safety Law California Gov. Gavin Newsom (D) signed an artificial intelligence safety measure ( SB 53 ), exactly one year after vetoing a similar but broader bill (SB 1047 [2024]). The new...
CA Enacts Bill Allowing Rideshare Drivers to Unionize California Gov. Gavin Newsom (D) signed a bill ( AB 1340 ) allowing drivers for ride-hailing companies to unionize and bargain collectively for better...
An international real estate investment firm wants to build a massive data center in north Delaware. The proposed campus would cover 6 million square feet across 11 structures , potentially creating what...
AI Industry Spending Big to Block State Regulations The AI industry has launched three super PACs in recent weeks that could spend over $100 million largely on statewide races next year. The industry...
* The views expressed in externally authored materials linked or published on this site do not necessarily reflect the views of LexisNexis Legal & Professional.
Policymakers in California, Colorado, Maryland and other states are considering ways to backfill pandemic-era federal health insurance subsidies expiring at the end of this year. Since states don’t have the resources to replace all that federal funding, health insurance premiums are likely to soar next year. (PLURIBUS NEWS)
New Hampshire Gov. Kelly Ayotte (R) signed a bill (HB 701) allowing patients to try experimental health treatments for rare diseases. The measure expands on a law enacted by the state in 2016. (WMUR)
—Compiled by SNCJ Managing Editor KOREY CLARK
Visit our webpage to connect with a LexisNexis® State Net® representative and learn how the State Net legislative and regulatory tracking service can help you identify, track, analyze and report on relevant legislative and regulatory developments.